BSD Medical (BSDM) Receives Review Questions from U.S. FDA for MTX-180 Premarket Clearance
BSD Medical Corporation (Nasdaq: BSDM) today announced that it has received review questions from the U.S. Food and Drug Administration (FDA) regarding the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. “We expected questions...
Get Alerted When News Hits On This Stock - FREE!